Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-124516

Chief Scientific Officer acquired 35,389 shares (conversion)

  • Chief Scientific Officer returned 35,389 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Reich Kristian Chief Scientific Officer 2025-12-19 Conversion +35,389 35,389 D: show line 1 in the form
Reich Kristian Chief Scientific Officer 2025-12-19 Returned to the company −35,389 0 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Reich Kristian Chief Scientific Officer 2025-12-19 Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −1,052 0 D: show line 3 in the form
Loading xslF345X05/ownership.xml…